Klinger W, Müller D
Acta Biol Med Ger. 1980;39(1):107-112.
Allyl isopropyl acetamide (AIA) is believed to destroy P-450 and to enhance the d-aminolevulinic acid synthetase (ALAS) activity by lowering the heme pool of the liver parenchymal cell, in this way weakening the negative feed back mechanism, which regulates ALAS synthesis at the translational level. Dose and time dependence of the AIA influence on cytochrome P-450 concentration and P-450 activity argues against this theory, supporting the hypothesis that AIA destroys P-450 only after administration of higher doses (> 300 mg/kg i. p.), but does not influence or even enhances P-450 concentration when given in lower doses which exert an increase in ALAS activity. 25--100 mg/kg AIA i. p. have no significant effect on ALAS activity, 200 mg/kg and higher doses up to 400 mg/kg cause dose-dependent increases in ALAS activity.
烯丙基异丙基乙酰胺(AIA)被认为会破坏细胞色素P-450,并通过降低肝实质细胞的血红素池来增强δ-氨基乙酰丙酸合成酶(ALAS)的活性,从而削弱在翻译水平调节ALAS合成的负反馈机制。AIA对细胞色素P-450浓度和P-450活性影响的剂量和时间依赖性与该理论相悖,支持了以下假说:AIA仅在给予较高剂量(>300mg/kg腹腔注射)后才会破坏P-450,但在给予较低剂量时,虽会使ALAS活性增加,却不会影响甚至会提高P-450浓度。腹腔注射25-100mg/kg AIA对ALAS活性无显著影响,200mg/kg及高达400mg/kg的更高剂量会导致ALAS活性呈剂量依赖性增加。